Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02912221 · ClinicalTrials.gov registry record · NA

Stepping Up For Inflammatory Arthritis

A NA study of Arthritis, Rheumatoid and Arthritis, Psoriatic, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT02912221 is a NA study of Arthritis, Rheumatoid and Arthritis, Psoriatic that has completed, run by University of Pennsylvania. The registered enrollment target is 71 participants, below the 639-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02912221, a NA study of Arthritis, Rheumatoid and Arthritis, Psoriatic, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

This study will examine the benefits of a monitored physical activity program for participants with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) using a wearable activity device (e.g.fitbit). The goals of this pilot study are to examine 1) whether an incentive is better than no incentive in maintaining an increased level of physical activity and 2) the benefits of physical activity on patient reported disease activity in inflammatory arthritis.

Interventions

  • OTHER Incentive

Study Locations (1)

Pennsylvania

  • Hospital at the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2017-04-24
Est. Completion 2019-11-24
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT02912221

The ClinicalTrials.gov registry entry for NCT02912221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 639-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (89% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which Incentive is the first listed.

NCT02912221 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02912221 about?

NCT02912221 is a clinical study titled "Stepping Up For Inflammatory Arthritis". This study will examine the benefits of a monitored physical activity program for participants with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) using a wearable activity device (e.g.fitbit). The goals of this pilot study are to examine 1) whether an incentive is better than no incentive i...

What is the current status of trial NCT02912221?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2017-04-24. Estimated completion is 2019-11-24.

What conditions does trial NCT02912221 study?

This clinical trial studies the following conditions: Arthritis, Rheumatoid, Arthritis, Psoriatic.

What interventions are being tested in trial NCT02912221?

The interventions under investigation include: Incentive (OTHER).

Who is sponsoring clinical trial NCT02912221?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02912221 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthritis, Rheumatoid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.